136 related articles for article (PubMed ID: 23162635)
1. Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models.
Zhou J; Wang L; Xu X; Tu Y; Qin S; Yin Y
Oncol Lett; 2012 Nov; 4(5):976-980. PubMed ID: 23162635
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
[TBL] [Abstract][Full Text] [Related]
3. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of recombinant human endostatin combined with cisplatin on rats with transplanted Lewis lung cancer.
Yu ZW; Ju YH; Yang CL; Yu HB; Luo Q; Ma YG; Liu YY
Asian Pac J Trop Med; 2015 Aug; 8(8):664-7. PubMed ID: 26321522
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma.
Zhou N; Hu G; Mei Q; Qiu H; Long G; Chen C; Guoqing H
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):62-66. PubMed ID: 21336725
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
[TBL] [Abstract][Full Text] [Related]
8. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.
Wu H; Deng J; Yu S; Wang X; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma.
Li Y; Huang P; Peng H; Yue H; Wu M; Liu S; Qin R; Fan J; Han Y
Cancer Manag Res; 2019; 11():3469-3479. PubMed ID: 31114380
[No Abstract] [Full Text] [Related]
12. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
[TBL] [Abstract][Full Text] [Related]
13. Experimental study of Endostar injection concomitant with cryoablation on lung adenocarcinoma A549 xenografts.
Ma CH; Jiang R; Li JD; Wang B; Sun LW; Lv Y
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6697-701. PubMed ID: 24377591
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
15. Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
Peng XC; Qiu M; Wei M; Tan BX; Ge J; Zhao Y; Chen Y; Cheng K; Zhou Y; Wu Y; Gong FM; Li Q; Xu F; Bi F; Liu JY
Cancer Chemother Pharmacol; 2012 Jan; 69(1):239-46. PubMed ID: 21706279
[TBL] [Abstract][Full Text] [Related]
16. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
Li Y; Tian Y; Jin F; Wu W; Long J; Ouyang J; Zhou Y
Curr Probl Cancer; 2020 Feb; 44(1):100492. PubMed ID: 32035692
[TBL] [Abstract][Full Text] [Related]
17. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
[TBL] [Abstract][Full Text] [Related]
18. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
[TBL] [Abstract][Full Text] [Related]
19. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma.
Guang-Wu H; Sunagawa M; Jie-En L; Shimada S; Gang Z; Tokeshi Y; Kosugi T
Laryngoscope; 2000 Dec; 110(12):2066-9. PubMed ID: 11129022
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
Deng G; Zhao DL; Li GC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
